Publications by authors named "Jason Esposito"

Claim this Profile
R
Relation between chelation and clinical outcomes in lower-risk patients with myelodysplastic syndromes: Registry analysis at 5 years.
Roger M Lyons, Billie J Marek, Carole Paley, Jason Esposito, Katie McNamara

Leuk Res· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of 24-month outcomes in chelated and non-chelated lower-risk patients with myelodysplastic syndromes in a prospective registry.
Roger M Lyons, Billie J Marek, Carole Paley, Jason Esposito, Lawrence Garbo

Leuk Res· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The palatability and tolerability of deferasirox taken with different beverages or foods.
Stuart L Goldberg, Patricia J Giardina, Deborah Chirnomas, Jason Esposito, Carole Paley

Pediatr Blood Cancer· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deferasirox reduces serum ferritin and labile plasma iron in RBC transfusion-dependent patients with myelodysplastic syndrome.
Alan F List, Maria R Baer, David P Steensma, Azra Raza, Jason Esposito

J Clin Oncol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis